kanamycin a has been researched along with minocycline in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, TK; Chan, EW; Chan, RC; Chin, ML; Chow, VC; Fung, DK; Hawkey, PM | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdeen, S; Ambrose, AJ; Anderson, GG; Chapman, E; Frankson, R; Horwich, AL; Johnson, SM; Mammadova, N; Salim, N; Schultz, PG; Summers, CM | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Gallagher, EE; Garner, AL; Kaur, T; Kerk, SA; Lorenz, DA; Menon, A; Sandoval, J | 1 |
| Diermeier, HF; Gordon, G; Kepenis, V; Sparano, BM; Yuda, N | 1 |
| Tsukamura, M | 1 |
| Estler, CJ | 1 |
| Waddell, AD; Walsh, WT; Wisseman, CL | 1 |
| Hoppes, WL; Lerner, PI | 1 |
| Akaishi, K; Kobayashi, Y; Nishio, T; Teramura, F | 1 |
| Coronato, S; Coto, CE; Vullo, D | 1 |
| Abe, S; Ikeda, T; Suegara, N; Yamaguchi, H | 1 |
| Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
1 review(s) available for kanamycin a and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
23 other study(ies) available for kanamycin a and minocycline
| Article | Year |
|---|---|
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Streptococcus | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
GroEL/ES inhibitors as potential antibiotics.
Topics: Anti-Bacterial Agents; Cell Line; Chaperonin 10; Chaperonin 60; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
Topics: | 2019 |
Assessment of ototoxic potential of minocycline in guinea pigs.
Topics: Animals; Auditory Perception; Guinea Pigs; Hearing; Kanamycin; Male; Microscopy, Electron; Minocycline; Nerve Endings; Organ of Corti; Photomicrography; Reflex; Sodium Chloride; Tetracyclines; Vestibule, Labyrinth | 1975 |
Differentiation between genera Rhodococcus and Nocardia by susceptibility testing to kanamycin and some other antituberculosis agents.
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Kanamycin; Kanamycin Resistance; Minocycline; Nocardia; Nocardia asteroides; Rhodococcus; Rifampin; Streptomycin | 1988 |
[Antibiotics. New aspects from the point of view of a pharmacologist].
Topics: Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Dihydrostreptomycin Sulfate; Doxycycline; Humans; Kanamycin; Lincomycin; Minocycline; Proteus; Pseudomonas; Streptomycin | 1974 |
In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Chick Embryo; Chloramphenicol; Culture Techniques; Dimethyl Sulfoxide; Doxycycline; Erythromycin; Gentamicins; Kanamycin; Minocycline; Neomycin; Oxacillin; Penicillin G; Rickettsia Infections; Rickettsia prowazekii; Rifampin; Streptomycin; Tetracycline; Ultrafiltration; Vancomycin | 1974 |
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis.
Topics: Adult; Aged; Ampicillin; Cephalosporins; Child; Chloramphenicol; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Gastrointestinal Diseases; Gentamicins; Humans; Kanamycin; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxacillin; Penicillin G; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Urologic Diseases; Vancomycin | 1974 |
[Clinical experience with minocycline (Minomycin) granules in pediatrics with special reference to urinary-tract infections (author's transl)].
Topics: Ampicillin; Cephalexin; Cephaloridine; Child; Child, Preschool; Chloramphenicol; Colistin; Escherichia coli; Female; Humans; Infant; Kanamycin; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Nalidixic Acid; Proteus; Streptomycin; Tetracycline; Tetracyclines; Urinary Tract Infections | 1974 |
A simple method to eliminate mycoplasma from cell cultures.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Cricetinae; Culture Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; Eukaryotic Cells; Humans; Kanamycin; Minocycline; Mycoplasma; Roxithromycin; Tumor Cells, Cultured; Tylosin | 1994 |
Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Kanamycin; Kidney; Mice; Mice, Inbred ICR; Minocycline; Piperacillin; Tetracycline | 1999 |
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2 | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |